Ocuphire Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ocuphire Pharma generated cash of -$1,112,000, which is less than the previous year. Cash used in financing activities reached the amount of $8,979,000 last year. Net change in cash is therefore $7,867,000.
Cash Flow
| 2014 | -11.04M | -22.66M | 24.84M |
|---|---|---|---|
| 2015 | -17.35M | 9.55M | 8.17M |
| 2016 | -13.22M | 4.48M | 10.12M |
| 2017 | -15.42M | -9.37M | 22.11M |
| 2018 | -18.93M | 11.91M | 6.87M |
| 2019 | -3.59M | -25K | 4.70M |
| 2020 | -6.79M | 539K | 21.12M |
| 2021 | -19.37M | -100K | 27.60M |
| 2022 | 14.31M | 0 | 3.78M |
| 2023 | -1.11M | 0 | 8.97M |
OCUP Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 42.63M | 24.53M | 16.39M | 1.53M | 451K | 8.89M | 11.57M | 10.19M | 9.82M | 18.68M |
Operating activities | ||||||||||
Net income | -9.98M | 17.88M | -56.69M | -24.62M | -6.16M | -14.36M | -25.29M | -9.30M | -14.38M | -18.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 6K | 4K | 4K | 8K | 3K | 48.21K | 42.35K | 32.91K | 27.49K | 38.55K |
Stock-based compensation expense | 3.51M | 1.80M | 1.91M | 1.50M | 308K | 177.31K | 1.04M | 0 | 1.03M | 0 |
| Deferred income tax benefit | 3.51M | 1.80M | 1.91M | 1.50M | 308K | 177.31K | 1.04M | 0 | 1.03M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 2.51M | -1.29M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 1.08M | -515K | 381K | 792K | -168K | -81.37K | 1.35M | 0 | 202.03K | 1.52M |
Cash generated by operating activities | -1.11M | 14.31M | -19.37M | -6.79M | -3.59M | -18.93M | -15.42M | -13.22M | -17.35M | -11.04M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -8.88M | 0 | -21.01M | -8.74M | -7.90M | -26.07M |
Investments In Property Plant And Equipment | 0 | 0 | -100K | -1.47M | -25K | -39.22K | -75.16K | -8.66K | -62.30K | 0 |
Acquisitions Net | 0 | 0 | 0 | 2.01M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -100K | 539K | -25K | 11.91M | -9.37M | 4.48M | 9.55M | -22.66M |
Financing activities | ||||||||||
Common Stock Issued | 9.22M | 4.42M | 28.49M | 21.15M | 7.65M | 6.87M | 22.11M | 10.12M | 8.17M | 18.63M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -4.41K | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -108K | -2.18M | 4.70M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 8.97M | 3.78M | 27.60M | 21.12M | 4.70M | 6.87M | 22.11M | 10.12M | 8.17M | 24.84M |
Net Change In Cash | 7.86M | 18.1M | 8.13M | 14.86M | 1.08M | -154.85K | -2.67M | 1.37M | 373.19K | -8.86M |
Cash at end of period | 50.50M | 42.63M | 24.53M | 16.39M | 1.53M | 8.74M | 8.89M | 11.57M | 10.19M | 9.82M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |